90 related articles for article (PubMed ID: 26672582)
1. Duodenal Adenocarcinoma: Profile and Predictors of Survival Outcomes.
Oyasiji T; Alosi J; Tan W; Wilfong C; Wilkinson N
Am Surg; 2015 Nov; 81(11):1125-33. PubMed ID: 26672582
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes in patients with duodenal adenocarcinoma.
Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
[TBL] [Abstract][Full Text] [Related]
3. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients.
Rose DM; Hochwald SN; Klimstra DS; Brennan MF
J Am Coll Surg; 1996 Aug; 183(2):89-96. PubMed ID: 8696551
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China.
Jiang QL; Huang XH; Chen YT; Zhang JW; Wang CF
Biomed Res Int; 2016; 2016():6491049. PubMed ID: 28116301
[No Abstract] [Full Text] [Related]
5. Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.
Shaib WL; Sharma R; Brutcher E; Kim S; Maithel SK; Chen Z; Kooby DA; Kauh J; Landry J; El-Rayes BF
J Surg Oncol; 2014 May; 109(6):556-60. PubMed ID: 24338561
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of curative and palliative treatment of duodenal adenocarcinoma].
Bendixen M; Dahl S; Fristrup C; Mortensen MB
Ugeskr Laeger; 2010 May; 172(18):1376-9. PubMed ID: 20444409
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.
Overman MJ; Kopetz S; Lin E; Abbruzzese JL; Wolff RA
Acta Oncol; 2010 May; 49(4):474-9. PubMed ID: 20397775
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer.
Sarela AI; Brennan MF; Karpeh MS; Klimstra D; Conlon KC
Ann Surg Oncol; 2004 Apr; 11(4):380-6. PubMed ID: 15070597
[TBL] [Abstract][Full Text] [Related]
10. Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival.
Struck A; Howard T; Chiorean EG; Clarke JM; Riffenburgh R; Cardenes HR
J Surg Oncol; 2009 Aug; 100(2):144-8. PubMed ID: 19544358
[TBL] [Abstract][Full Text] [Related]
11. Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experience.
Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2012 Dec; 35(6):533-6. PubMed ID: 21659832
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis.
Meijer LL; Alberga AJ; de Bakker JK; van der Vliet HJ; Le Large TYS; van Grieken NCT; de Vries R; Daams F; Zonderhuis BM; Kazemier G
Ann Surg Oncol; 2018 Sep; 25(9):2681-2692. PubMed ID: 29946997
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma.
Tran TB; Qadan M; Dua MM; Norton JA; Poultsides GA; Visser BC
Surgery; 2015 Aug; 158(2):486-93. PubMed ID: 26013988
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of radical resection for locally advanced duodenal adenocarcinoma.
Bucher P; Gervaz P; Morel P
Hepatogastroenterology; 2005; 52(66):1727-9. PubMed ID: 16334766
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of 119 small bowel adenocarcinoma in Chinese patients.
Guo XC; Mao ZY; Su D; Wang LJ; Zhang TT; Bai L
Cancer Invest; 2014 Jun; 32(5):178-83. PubMed ID: 24654694
[TBL] [Abstract][Full Text] [Related]
16. The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study.
Sakae H; Kanzaki H; Nasu J; Akimoto Y; Matsueda K; Yoshioka M; Nakagawa M; Hori S; Inoue M; Inaba T; Imagawa A; Takatani M; Takenaka R; Suzuki S; Fujiwara T; Okada H
Br J Cancer; 2017 Nov; 117(11):1607-1613. PubMed ID: 28982111
[TBL] [Abstract][Full Text] [Related]
17. Surgical management and outcome in primary adenocarcinoma of the small bowel.
Agrawal S; McCarron EC; Gibbs JF; Nava HR; Wilding GE; Rajput A
Ann Surg Oncol; 2007 Aug; 14(8):2263-9. PubMed ID: 17549572
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of primary duodenal adenocarcinoma.
Hu JX; Miao XY; Zhong DW; Dai WD; Liu W; Hu W
Hepatogastroenterology; 2006; 53(72):858-62. PubMed ID: 17153441
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of surgical resection for primary duodenal adenocarcinoma: A systematic review.
Li D; Si X; Wan T; Zhou Y
Asian J Surg; 2019 Jan; 42(1):46-52. PubMed ID: 29802028
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for primary duodenal adenocarcinoma.
Lee HG; You DD; Paik KY; Heo JS; Choi SH; Choi DW
World J Surg; 2008 Oct; 32(10):2246-52. PubMed ID: 18668288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]